Logo image of IXHL

INCANNEX HEALTHCARE INC (IXHL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IXHL - US45333F1093 - Common Stock

0.389 USD
-0.02 (-4.09%)
Last: 1/7/2026, 8:00:02 PM
0.3908 USD
+0 (+0.46%)
Pre-Market: 1/8/2026, 6:56:06 AM
Fundamental Rating

4

Taking everything into account, IXHL scores 4 out of 10 in our fundamental rating. IXHL was compared to 191 industry peers in the Pharmaceuticals industry. While IXHL has a great health rating, there are worries on its profitability. IXHL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IXHL had negative earnings in the past year.
IXHL had a negative operating cash flow in the past year.
IXHL had negative earnings in each of the past 5 years.
In the past 5 years IXHL always reported negative operating cash flow.
IXHL Yearly Net Income VS EBIT VS OCF VS FCFIXHL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -59.56%, IXHL is doing worse than 64.40% of the companies in the same industry.
IXHL has a Return On Equity of -60.88%. This is comparable to the rest of the industry: IXHL outperforms 47.64% of its industry peers.
Industry RankSector Rank
ROA -59.56%
ROE -60.88%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IXHL Yearly ROA, ROE, ROICIXHL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IXHL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IXHL Yearly Profit, Operating, Gross MarginsIXHL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K -200K -250K

More info and screens

8

2. Health

2.1 Basic Checks

IXHL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IXHL Yearly Shares OutstandingIXHL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
IXHL Yearly Total Debt VS Total AssetsIXHL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

IXHL has an Altman-Z score of 44.46. This indicates that IXHL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 44.46, IXHL belongs to the best of the industry, outperforming 94.76% of the companies in the same industry.
IXHL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 44.46
ROIC/WACCN/A
WACCN/A
IXHL Yearly LT Debt VS Equity VS FCFIXHL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

IXHL has a Current Ratio of 47.51. This indicates that IXHL is financially healthy and has no problem in meeting its short term obligations.
IXHL's Current ratio of 47.51 is amongst the best of the industry. IXHL outperforms 98.43% of its industry peers.
A Quick Ratio of 47.51 indicates that IXHL has no problem at all paying its short term obligations.
IXHL has a Quick ratio of 47.51. This is amongst the best in the industry. IXHL outperforms 98.43% of its industry peers.
Industry RankSector Rank
Current Ratio 47.51
Quick Ratio 47.51
IXHL Yearly Current Assets VS Current LiabilitesIXHL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

IXHL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.16%.
IXHL shows a strong growth in Revenue. In the last year, the Revenue has grown by 616.67%.
IXHL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.33% yearly.
EPS 1Y (TTM)-19.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.26%
Revenue 1Y (TTM)616.67%
Revenue growth 3Y-44.73%
Revenue growth 5Y-36.33%
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 42.45% on average over the next years. This is a very strong growth
IXHL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 1900.01% yearly.
EPS Next Y97.08%
EPS Next 2Y42.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y1900.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IXHL Yearly Revenue VS EstimatesIXHL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2027 20M 40M 60M
IXHL Yearly EPS VS EstimatesIXHL Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 -0.5 -1 -1.5 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

IXHL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 6.18, which indicates a rather cheap valuation of IXHL.
Based on the Price/Forward Earnings ratio, IXHL is valued cheaply inside the industry as 93.72% of the companies are valued more expensively.
IXHL is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.18
IXHL Price Earnings VS Forward Price EarningsIXHL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IXHL Per share dataIXHL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

IXHL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IXHL's earnings are expected to grow with 42.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.45%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IXHL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

INCANNEX HEALTHCARE INC

NASDAQ:IXHL (1/7/2026, 8:00:02 PM)

Premarket: 0.3908 +0 (+0.46%)

0.389

-0.02 (-4.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-14 2025-11-14
Earnings (Next)02-12 2026-02-12
Inst Owners1.07%
Inst Owner Change0%
Ins Owners12.79%
Ins Owner Change91.78%
Market Cap134.68M
Revenue(TTM)86.00K
Net Income(TTM)-46.88M
AnalystsN/A
Price TargetN/A
Short Float %7.3%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)94.86%
EPS NY rev (1m)0%
EPS NY rev (3m)97.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.18
P/S 1566.09
P/FCF N/A
P/OCF N/A
P/B 1.75
P/tB 1.75
EV/EBITDA N/A
EPS(TTM)-1.36
EYN/A
EPS(NY)0.06
Fwd EY16.19%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS0.22
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -59.56%
ROE -60.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 11.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 47.51
Quick Ratio 47.51
Altman-Z 44.46
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.26%
EPS Next Y97.08%
EPS Next 2Y42.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)616.67%
Revenue growth 3Y-44.73%
Revenue growth 5Y-36.33%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y1900.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

INCANNEX HEALTHCARE INC / IXHL FAQ

What is the ChartMill fundamental rating of INCANNEX HEALTHCARE INC (IXHL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IXHL.


Can you provide the valuation status for INCANNEX HEALTHCARE INC?

ChartMill assigns a valuation rating of 4 / 10 to INCANNEX HEALTHCARE INC (IXHL). This can be considered as Fairly Valued.


What is the profitability of IXHL stock?

INCANNEX HEALTHCARE INC (IXHL) has a profitability rating of 0 / 10.